NEOG Form 4: Chief Legal Officer Acquires 119,705 Shares at $5.43
Amy M. Rocklin, Chief Legal Officer of Neogen Corp (NEOG), reported equity awards and option grants that increase her direct ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amy M. Rocklin, Chief Legal Officer of Neogen Corp (NEOG), reported equity awards and option grants that increase her direct ownership. She acquired 119,705 common shares at $5.43 per share, bringing her direct beneficial ownership to 156,556 shares. In addition, she received a derivative award giving the right to buy 307,680 shares at an exercise price of $5.43, exercisable through 08/15/2035.
The filing notes the option grants vest in equal annual installments over the first three anniversaries of the grant and that performance stock units vest in full at the three-year anniversary. All reported holdings are direct ownership.
Positive
- Increased insider alignment: Reporting person increased direct ownership to 156,556 shares, strengthening executive stake in NEOG
- Long-term incentives: Options and PSUs with multi-year vesting encourage retention and alignment with long-term performance
Negative
- Potential future dilution: The right to buy 307,680 shares could dilute existing shareholders if exercised and issued as shares
- Concentration of executive compensation in equity: Heavy equity awards may lead to share issuance upon vesting/exercise
Insights
TL;DR: Routine executive equity compensation increases insider stake; not immediately dilutive but adds potential future shares.
The transactions reflect standard long-term incentive compensation: a mix of vested shares, options and PSUs that align the Chief Legal Officer with shareholder outcomes. The exercised price and warrant term ($5.43 exercise through 2035) imply long-duration optionality. Vesting schedules—annual installments for options and a three-year cliff for PSUs—limit immediate selling pressure while creating future potential dilution if options are exercised or PSUs vest in shares.
TL;DR: Governance-wise this is a typical senior officer award with standard vesting; disclosure is complete for material insider reporting.
The Form 4 discloses acquisition quantities, prices and vesting mechanics, enabling investors to assess alignment and potential dilution. The direct ownership increase to 156,556 shares and the 307,680-share option position are material to executive alignment but do not indicate a change in control or unusual governance action.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) | 307,680 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 119,705 | $5.43 | $650K |
Footnotes (2)
- F1. Options vest in equal annual installments on each of the first three anniversary dates of the grants
- F2. PSUs vest in total at the end of the three year anniversary date of the grant
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NEOG insider Amy M. Rocklin acquire?
What are the terms of the option/derivative award reported for NEOG?
What are the vesting schedules for the awards?
Is the ownership reported direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.